Dr. Biazzo is the author and co-author of peer-reviewed publications on the microbiome, molecular biology, and translational medicine. He has coordinated or participated in more than ten international research projects in collaboration with European universities, hospitals, and biotechnology centers.
1 million+ people
5,000+ medical reports
30+ projects
Ph.D.
6+ universities
50+ courses
Ages 12 and up
4 continents
Microorganisms 2023
11(3), 804
Nanopore sequencing is a promising technology used for sequencing 16S rRNA gene amplicons, as it is capable of providing full-length 16S reads and has a low upfront cost, allowing research groups to set up their own sequencing workflows. To evaluate whether Nanopore, with the improved error rate of Kit 12 chemistry, should be adopted as the preferred sequencing technology over Illumina for sequencing 16S amplicons of the gut microbiota, we used a simulated community and human fecal samples to compare community diversity, richness, and structure at the species level, as well as the reproducibility of the results.
Front. Neurosci., 12 October 2021
Sec. Gut-Brain Axis
The physiological functions or pathological dysfunctions of the brain undoubtedly depend on the activity of both neuronal and non-neuronal populations. However, in recent decades, compelling and growing evidence has shown that the brain is not the only key player. In fact, the so-called “gut brain,” consisting of the microbial populations living in the gut, forms a symbiotic superorganism that weighs as much as the human brain and communicates intensively with it via the gut-brain axis.
Microorganisms 2023
11(2), 417
Trends in Microbiology
P34-46
Analyzing the cross-correlations between the virome and the bacteriome within the bidirectional microbiota-host relationship is essential for elucidating the link to the severity and progression of respiratory infections.
The study of the microbiome and its interactions with the host can help identify and classify the characteristics of respiratory diseases, including the phenotypes of coronavirus disease 2019 (COVID-19).
Front. Cell. Infect. Microbiol.
Sec. Clinical and Diagnostic Microbiology and Immunology
The timely and accurate identification of bloodborne pathogens is critical for targeted antimicrobial therapy in sepsis. Conventional blood cultures remain the standard of care (SoC) for pathogen identification, but they have limitations such as low sensitivity and prolonged turnaround times, hindering timely and targeted antimicrobial management. Advances in next-generation sequencing (NGS) offer the potential for rapid, comprehensive, culture-independent pathogen detection, as well as the ability to predict antimicrobial resistance. This study evaluated the diagnostic performance of PISTE™ technology, an NGS-based diagnostic workflow that combines whole-genome 16S rRNA sequencing and metagenomic analysis for the diagnosis of circulating bacteria in sepsis.
Int. J. Mol. Sci. 2025
26(11), 5000
Mar. Drugs 2018
16(12), 504
Recently, marine algae and their extracts have attracted considerable interest in the pharmaceutical industry as a source of bioactive compounds. Several studies have demonstrated the cytotoxic activity of macroalgae on various cancer cell lines, and their consumption has been proposed as a chemopreventive agent against various cancers, such as breast, cervical, and colon cancer. Data on the chemical properties of the brown alga Padina sp. are limited, and none exist that are accompanied by a comprehensive evaluation of its biological activity against osteosarcoma (OS).
Front. Microbiomes
Sec. Host and Microbe Associations
Neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) have increasingly been linked to alterations in the gut microbiota, although the reported microbial profiles remain heterogeneous and often lack adequate taxonomic resolution. In the present study, we applied full-length 16S rRNA gene sequencing to characterize the composition of the gut microbiota in 152 individuals, including patients with AD (n = 37), PD (n = 65), and age-matched healthy controls (n = 50), using a unified bioinformatic and statistical framework adjusted for relevant demographic covariates.
Bambin Gesù Hospital
Reithera Srl
Study to identify nasal biomarkers associated with the severity of COVID-19 and their correlations with the respiratory microbiome. Project aimed at developing rapid tests for tracking viral variants.
TopMD Precision Medicine Ltd
Malta Enterprise
Analysis of the skin and gut microbiome in individuals aged 50 to 80 to identify phenotypes predictive of healthy aging and biomarkers of chronic inflammation.
Malta Enterprise
Research on the interaction between diet, exercise, and the gut microbiota. The study aims to develop personalized nutrition plans to improve athletic performance and recovery.
Cancer Hub
Xjenza Malta
A comparative analysis of the gut microbiome and immune response in cancer patients. The goal is to tailor immunotherapy treatments based on individual microbial profiles.
Xjenza Malta
Development and validation of a topical probiotic serum containing Lactobacillus for the treatment of acne. This includes in vitro efficacy, safety, and genomic testing for registration as a dermatological device.
The BioArt
AI Research Unit
Integrating metagenomic analysis and artificial intelligence to create predictive models of women’s health based on the gut and vaginal microbiome.
The BioArt
ERA Talents
Advanced research and training program for the development of biomarkers for neurodegenerative diseases, with a focus on microbiome-brain interactions and omics technologies.
Xjenza Malta
Development of genomic methods for the rapid identification and quantification of microorganisms responsible for sepsis and antibiotic resistance genes.
Xjenza Malta
Ministry for Health Malta
A pioneering study that integrates the microbiome and school nutrition to prevent childhood obesity through dietary and health education programs in elementary schools.
Awards and Honors
The first visit is free. No obligation.
Just the certainty of finally having an answer tailored to your needs.
Available in-person in Siena, Florence, Milan, Rome, Venice, Salerno, Athens, Malta, and online
Response within 24 hours
